|
Index of reports
> Life Threatening Events (106)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Risperdal (Risperidone) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 106 Next >>
Possible Risperdal side effects in male
Reported by a physician from Romania on 2012-08-27
Patient: male, weighing 85.0 kg (187.0 pounds)
Reactions: Blood Pressure Increased, Hospitalisation, Pleurisy, Catatonia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Risperdal
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-16
Risperidone
Start date: 2012-05-04
End date: 2012-07-04
Risperidone
Indication: Schizophrenia
Other drugs received by patient: Lorazepam
Possible Risperdal side effects in male
Reported by a physician from United States on 2012-08-24
Patient: male, weighing 61.7 kg (135.7 pounds)
Reactions: Pulmonary Embolism
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Risperdal
Dosage: im every 2 weeks
Indication: Schizophrenia
Start date: 2006-01-01
Risperidone
Dosage: 2 mg, by mouth, qhs
Indication: Schizophrenia
Start date: 2006-01-01
End date: 2012-01-01
Other drugs received by patient: Warfarin Sodium
Possible Risperdal side effects in 20 year old male
Reported by a physician from Austria on 2012-08-07
Patient: 20 year old male
Reactions: Hyperthermia, Disseminated Intravascular Coagulation, Coma, Status Epilepticus, Off Label Use, Multi-Organ Failure, Pharyngeal Haemorrhage, Laryngeal Haemorrhage
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Risperdal
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Sertraline Hydrochloride
Indication: Product Used FOR Unknown Indication
Topamax
Dosage: 100 mg twice daily (1-0-1) with increasing dosage
Administration route: Oral
Start date: 2012-01-01
End date: 2012-07-01
Topamax
Dosage: graduated increase with 25 mg
Administration route: Oral
Indication: Abnormal Behaviour
Possible Risperdal side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-06
Patient: male
Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Dystonia, Grimacing, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Suicide Attempt, Disturbance in Attention, Tardive Dyskinesia, Extrapyramidal Disorder, Gait Disturbance, Hypertension
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Zyprexa
Indication: Schizophrenia
Possible Risperdal side effects in 69 year old male
Reported by a physician from France on 2012-07-26
Patient: 69 year old male
Reactions: Coma
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Loxapine HCL
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-03
End date: 2012-05-03
Risperdal
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-03
End date: 2012-05-03
Tranxene
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-03
End date: 2012-05-03
Valium
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-03
End date: 2012-05-03
Possible Risperdal side effects in 48 year old male
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-07-26
Patient: 48 year old male
Reactions: Vomiting, Restlessness, Potentiating Drug Interaction, Myocardial Ischaemia, Suicidal Ideation, Arrhythmia, Speech Disorder, Anxiety, Dysstasia, Sleep Disorder, Major Depression, Myocardial Infarction, Scar
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Bupropion Hydrochloride
Dosage: see image
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-01-30
End date: 2012-03-15
Bupropion Hydrochloride
Dosage: see image
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-01-14
End date: 2012-01-29
Bupropion Hydrochloride
Dosage: see image
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-03-16
End date: 2012-04-04
Bupropion Hydrochloride
Dosage: see image
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-04-05
End date: 2012-04-09
Bupropion Hydrochloride
Dosage: see image
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-04-10
End date: 2012-04-14
Eunerpan (Eunerpan-Melperone
Dosage: (50 mg oral), (as needed: 100 mg twice and 50 mg once oral)
Administration route: Oral
Indication: Suicidal Ideation
Start date: 2012-04-14
End date: 2012-04-14
Eunerpan (Eunerpan-Melperone
Dosage: (50 mg oral), (as needed: 100 mg twice and 50 mg once oral)
Administration route: Oral
Indication: Anxiety
Start date: 2012-04-14
End date: 2012-04-14
Eunerpan (Eunerpan-Melperone
Dosage: (50 mg oral), (as needed: 100 mg twice and 50 mg once oral)
Administration route: Oral
Indication: Sleep Disorder
Start date: 2012-04-14
End date: 2012-04-14
Eunerpan (Eunerpan-Melperone
Dosage: (50 mg oral), (as needed: 100 mg twice and 50 mg once oral)
Administration route: Oral
Indication: Major Depression
Start date: 2012-04-14
End date: 2012-04-14
Risperdal
Dosage: (df oral)
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-02-15
End date: 2012-04-14
Other drugs received by patient: Ramipril; Bisoprolol Fumarate
Possible Risperdal side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-25
Patient: male
Reactions: Coma
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Loxapine HCL
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-03
End date: 2012-05-03
Risperdal
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-03
End date: 2012-05-03
Tranxene
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-03
End date: 2012-05-03
Valium
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-03
End date: 2012-05-03
Possible Risperdal side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-23
Patient: male
Reactions: Ischaemic Stroke, Psychiatric Decompensation
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Loxapine HCL
Administration route: Oral
Indication: Persecutory Delusion
Start date: 2010-12-02
End date: 2010-12-08
Risperdal
Administration route: Oral
Start date: 2010-12-02
End date: 2010-12-08
Risperdal
Administration route: Oral
Start date: 2010-11-23
Risperdal
Administration route: Oral
Risperdal
Administration route: Oral
Indication: Persecutory Delusion
Start date: 2010-12-16
Risperdal Consta
Indication: Persecutory Delusion
Start date: 2010-12-03
End date: 2010-12-03
Tercian
Administration route: Oral
Indication: Persecutory Delusion
Start date: 2010-07-09
End date: 2010-12-02
Zyprexa
Administration route: Oral
Indication: Persecutory Delusion
Start date: 2010-07-09
End date: 2010-11-23
Other drugs received by patient: Imovane; Lepticur; Lepticur; Polyethylene Glycol; Escitalopram
Possible Risperdal side effects in 31 year old male
Reported by a physician from Japan on 2012-07-13
Patient: 31 year old male
Reactions: Lung Disorder
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Abilify
Administration route: Oral
Risperdal
Possible Risperdal side effects in 52 year old male
Reported by a physician on 2012-07-05
Patient: 52 year old male
Reactions: Blood Pressure Increased, Vomiting, Vomiting Projectile, Hyponatraemia, Polydipsia Psychogenic, Skin Disorder, Epilepsy, Dysstasia, Diarrhoea, Memory Impairment, Altered State of Consciousness
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Aldactone
Dosage: 50mg/day, oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Ciatyl-Z Acuphase (Zuclopenthixol Acetate)
Dosage: 100mg single, intramuscular
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-16
End date: 2011-08-16
Palmiperidone Palmitate (Paliperidone Palmitate)
Dosage: 150mg single intramuscular, intramuscular, 100mg single, intramuscular, 100mg single, intramuscular
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-02
End date: 2011-08-02
Palmiperidone Palmitate (Paliperidone Palmitate)
Dosage: 150mg single intramuscular, intramuscular, 100mg single, intramuscular, 100mg single, intramuscular
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-10
End date: 2011-08-10
Ramipril
Dosage: 5mg/day, oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Risperdal
Dosage: 4mg.day, oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-14
End date: 2011-08-22
Other drugs received by patient: Vitamin B12; Folic Acid; Lorazepam; Carvedilol; Aspirin
Possible Risperdal side effects in male
Reported by a consumer/non-health professional from United States on 2012-07-03
Patient: male
Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Disturbance in Attention, Suicide Attempt, Tardive Dyskinesia, Gait Disturbance, Extrapyramidal Disorder, Hypertension
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Zyprexa
Indication: Schizophrenia
Possible Risperdal side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-06-29
Patient: female
Reactions: Incorrect Route of Drug Administration, Mutism, Hyperkalaemia, Encephalitis, Hepatic Failure, Multi-Organ Failure, Acute Respiratory Distress Syndrome, Neuroleptic Malignant Syndrome, Gastrointestinal Obstruction, Renal Failure Acute, Hypertriglyceridaemia, Clonus, Cytolytic Hepatitis, Status Epilepticus, Convulsion, Cardiac Failure, Encephalitis Autoimmune, Septic Shock
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Citalopram Hydrobromide
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2009-02-01
End date: 2010-08-13
Gardasil
Dosage: injectable suspension. human papilloma virus vaccine [types 6, 11, 16, 18] (recombinant, adsorbed)
Indication: Immunisation
Start date: 2008-12-01
End date: 2009-04-01
Risperdal
Indication: Product Used FOR Unknown Indication
Start date: 2010-08-01
End date: 2010-08-13
Tercian
Dosage: dose : 50 mg/ 5 ml
Indication: Product Used FOR Unknown Indication
Start date: 2010-08-01
End date: 2010-08-13
Other drugs received by patient: Lorazepam
Possible Risperdal side effects in 52 year old male
Reported by a physician from Germany on 2012-06-27
Patient: 52 year old male
Reactions: Blood Pressure Increased, Vomiting, Diarrhoea, Hyponatraemia, Altered State of Consciousness, Epilepsy
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Aldactone
Dosage: 50 mg/day
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Ciatyl-Z Acuphase
Dosage: 100 mg, single
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-16
End date: 2011-08-16
Paliperidone Palmitate
Dosage: 100 mg, single
Start date: 2011-08-10
End date: 2011-08-10
Paliperidone Palmitate
Dosage: 150 mg, single
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-02
End date: 2011-08-02
Ramipril
Dosage: 5 mg/day
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Risperdal
Dosage: 4 mg/day
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-14
End date: 2011-08-22
Other drugs received by patient: Lorazepam; Folic Acid; Acetylsalicylic Acid; Carvedilol; Vitamin B-12
Possible Risperdal side effects in male
Reported by a physician from United States on 2012-06-26
Patient: male
Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Suicide Attempt, Disturbance in Attention, Gait Disturbance, Extrapyramidal Disorder, Tardive Dyskinesia, Hypertension
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Zyprexa
Indication: Schizophrenia
Possible Risperdal side effects in 25 year old male
Reported by a physician from Switzerland on 2012-06-26
Patient: 25 year old male
Reactions: Suicide Attempt, Joint Injury
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Escitalopram
Administration route: Oral
Indication: Depression
Start date: 2011-12-15
Lorazepam
Administration route: Oral
Start date: 2012-03-05
End date: 2012-03-05
Lorazepam
Administration route: Oral
Start date: 2012-03-09
End date: 2012-03-09
Lorazepam
Administration route: Oral
Start date: 2012-03-08
End date: 2012-03-08
Lorazepam
Administration route: Oral
Start date: 2012-03-10
End date: 2012-03-29
Risperdal
Administration route: Oral
Indication: Depression
Start date: 2012-01-26
End date: 2012-02-08
Risperdal
Administration route: Oral
Start date: 2012-02-18
End date: 2012-03-06
Risperdal
Administration route: Oral
Start date: 2012-03-20
End date: 2012-03-28
Risperdal
Administration route: Oral
Start date: 2012-03-07
End date: 2012-03-19
Risperdal
Administration route: Oral
Start date: 2012-02-09
End date: 2012-02-17
Seroquel
Administration route: Oral
Start date: 2012-03-06
End date: 2012-03-06
Possible Risperdal side effects in female
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-06-26
Patient: female
Reactions: Off Label Use, Encephalitis Autoimmune, Neuroleptic Malignant Syndrome
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Citalopram Hydrobromide
Dosage: 10 mg
Administration route: Oral
Start date: 2009-02-01
End date: 2010-08-13
Gardasil
Indication: Immunisation
Start date: 2008-12-01
End date: 2009-04-01
Risperdal
Start date: 2010-08-01
End date: 2010-08-13
Tercian
Start date: 2010-08-01
End date: 2010-08-13
Other drugs received by patient: Lorazepam
Possible Risperdal side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-06-25
Patient: female
Reactions: Incorrect Route of Drug Administration, Hyperkalaemia, Mutism, Encephalitis, Hepatic Failure, Multi-Organ Failure, Acute Respiratory Distress Syndrome, Neuroleptic Malignant Syndrome, Renal Failure Acute, Hypertriglyceridaemia, Gastrointestinal Obstruction, Cytolytic Hepatitis, Clonus, Status Epilepticus, Convulsion, Cardiac Failure, Encephalitis Autoimmune, Septic Shock
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Citalopram Hydrobromide
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2009-02-01
End date: 2010-08-13
Gardasil
Dosage: injectable suspension. human papilloma virus vaccine [types 6, 11, 16, 18] (recombinant, adsorbed)
Indication: Immunisation
Start date: 2008-12-01
End date: 2009-04-01
Risperdal
Indication: Product Used FOR Unknown Indication
Start date: 2010-08-01
End date: 2010-08-13
Tercian
Dosage: dose : 50 mg/ 5 ml
Indication: Product Used FOR Unknown Indication
Start date: 2010-08-01
End date: 2010-08-13
Other drugs received by patient: Lorazepam
Possible Risperdal side effects in 25 year old male
Reported by a physician from Switzerland on 2012-06-25
Patient: 25 year old male
Reactions: Suicide Attempt
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Escitalopram
Administration route: Oral
Indication: Depression
Start date: 2011-12-15
Lorazepam
Administration route: Oral
Start date: 2012-03-05
End date: 2012-03-05
Lorazepam
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-03-09
Lorazepam
Administration route: Oral
Start date: 2012-03-10
Lorazepam
Administration route: Oral
Start date: 2012-03-08
Risperdal
Administration route: Oral
Start date: 2012-02-09
End date: 2012-02-17
Risperdal
Administration route: Oral
Start date: 2012-02-18
End date: 2012-03-06
Risperdal
Administration route: Oral
Indication: Depression
Start date: 2012-01-26
End date: 2012-02-08
Risperdal
Administration route: Oral
Start date: 2012-03-07
End date: 2012-03-19
Risperdal
Administration route: Oral
Start date: 2012-03-20
End date: 2012-03-28
Seroquel
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-03-06
End date: 2012-03-06
Possible Risperdal side effects in 30 year old male
Reported by a physician from Germany on 2012-06-22
Patient: 30 year old male
Reactions: Confusional State, Rhabdomyolysis, Restlessness, Body Temperature Increased, Tachycardia, Abnormal Behaviour, Aggression, Irritability, Bronchitis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Ciatyl
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-01-10
End date: 2012-01-10
Ciatyl
Administration route: Oral
Start date: 2012-01-11
End date: 2012-01-12
Haldol
Indication: Product Used FOR Unknown Indication
Start date: 2012-01-12
Haldol
Start date: 2012-01-12
Risperdal
Administration route: Oral
Start date: 2012-01-10
End date: 2012-01-10
Risperdal
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-01-17
Risperdal
Administration route: Oral
Start date: 2012-01-11
End date: 2012-01-12
Other drugs received by patient: Diazepam; Diazepam; Diazepam
Possible Risperdal side effects in 52 year old male
Reported by a physician from Germany on 2012-06-21
Patient: 52 year old male
Reactions: Vomiting, Diarrhoea, Presyncope, Hyponatraemia, Hypertension, Epilepsy, Altered State of Consciousness
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Aldactone
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Ciatyl-Z Acuphase
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-16
End date: 2011-08-16
Paliperidone
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-02
End date: 2011-08-02
Paliperidone
Start date: 2011-08-10
End date: 2011-08-10
Ramipril
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Risperdal
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-14
End date: 2011-08-22
Other drugs received by patient: Folic Acid; Carvedilol; Vitamin B-12; Aspirin; Lorazepam
Possible Risperdal side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-06-20
Patient: female
Reactions: Incorrect Route of Drug Administration, Mutism, Hyperkalaemia, Encephalitis, Hepatic Failure, Multi-Organ Failure, Acute Respiratory Distress Syndrome, Neuroleptic Malignant Syndrome, Gastrointestinal Obstruction, Hypertriglyceridaemia, Renal Failure Acute, Cytolytic Hepatitis, Clonus, Status Epilepticus, Convulsion, Cardiac Failure, Encephalitis Autoimmune, Septic Shock
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Citalopram
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2009-02-01
End date: 2010-08-13
Risperdal
Indication: Product Used FOR Unknown Indication
Start date: 2010-08-01
End date: 2010-08-13
Tercian
Dosage: dose : 50 mg/ 5 ml
Indication: Product Used FOR Unknown Indication
Start date: 2010-08-01
End date: 2010-08-13
Other drugs received by patient: Lorazepam; Gardasil
Possible Risperdal side effects in 41 year old male
Reported by a physician from Germany on 2012-06-18
Patient: 41 year old male
Reactions: Pulmonary Embolism
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Risperdal
Administration route: Oral
Start date: 2012-03-01
Risperdal
Administration route: Oral
Indication: Product Used FOR Unknown Indication
End date: 2012-02-29
Risperdal Consta
Indication: Product Used FOR Unknown Indication
Start date: 2012-04-12
End date: 2012-04-12
Risperdal Consta
Start date: 2012-03-29
End date: 2012-03-29
Other drugs received by patient: Lorazepam; Bisoprolol Fumarate; Remergil; Remergil; Lorazepam; Remergil; Remergil; Venlafaxine Hydrochloride; Remergil; Lorazepam; Lorazepam; Lorazepam; Venlafaxine Hydrochloride
Possible Risperdal side effects in male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-06-04
Patient: male, weighing 57.0 kg (125.4 pounds)
Reactions: Pneumonia, Staphylococcal Infection, Sepsis, Malnutrition, Neuroleptic Malignant Syndrome
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Risperdal
Administration route: Oral
Indication: Schizophrenia
Risperdal Consta
Indication: Schizophrenia
Start date: 2011-06-18
Possible Risperdal side effects in 58 year old male
Reported by a consumer/non-health professional from United States on 2012-06-04
Patient: 58 year old male, weighing 77.1 kg (169.6 pounds)
Reactions: Concussion, Road Traffic Accident, JAW Disorder, Disturbance in Attention
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Risperdal
Possible Risperdal side effects in 70 year old male
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-05-31
Patient: 70 year old male
Reactions: Increased Upper Airway Secretion, Pneumonia, Hallucination, Visual, Unresponsive To Stimuli, Insomnia
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Amlodipine
Dosage: 5 mg; po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
End date: 2011-11-21
Dominal (Prothipendyl Hydrochloride)
Dosage: 40 mg; po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-11-20
End date: 2011-11-20
Melphalan Hydrochloride
Dosage: po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
End date: 2011-11-17
Mirtazapine
Dosage: 45 mg; po, 30 mg; po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-11-18
End date: 2011-11-21
Mirtazapine
Dosage: 45 mg; po, 30 mg; po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
End date: 2011-11-17
Risperdal
Dosage: 1.5 mg; po, 2 mg; po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
End date: 2011-11-17
Risperdal
Dosage: 1.5 mg; po, 2 mg; po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-11-18
End date: 2011-11-21
Tilidin (Valoron N / 00628301 / )
Dosage: 208 mg; po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
End date: 2011-11-21
Other drugs received by patient: Jonosteril; Pantoprazole; Metformin HCL; Ibuprofen
Possible Risperdal side effects in 33 year old male
Reported by a physician from Italy on 2012-05-30
Patient: 33 year old male
Reactions: Intentional Overdose, Tachycardia, Self Injurious Behaviour
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Risperdal
Administration route: Oral
Risperdal
Administration route: Oral
Indication: Schizophrenia
Start date: 2012-03-19
End date: 2012-03-19
Possible Risperdal side effects in 46 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-23
Patient: 46 year old male
Reactions: Haptoglobin Decreased, Pancytopenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Ketek
Administration route: Oral
Start date: 2011-01-24
End date: 2011-02-01
Norvir
Administration route: Oral
Indication: HIV Infection
End date: 2012-02-01
Risperdal
Administration route: Oral
Start date: 2009-01-01
End date: 2011-02-01
Other drugs received by patient: Atazanavir Sulfate; Corticosteroid NOS; Trimeprazine Tartrate; Emtricitabine / Tenofovir Disoproxil Fumarate; Valium; Desmopressin Acetate; Tazobactam; Bactrim
Possible Risperdal side effects in male
Reported by a physician from France on 2012-05-22
Patient: male
Reactions: Jaundice, Haptoglobin Decreased, Pancytopenia, Drug Interaction, Ascites, Lung Disorder, Apraxia, Oedema Peripheral
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Risperdal
Other drugs received by patient possibly interacting with the suspect drug:
Ketek
Administration route: Oral
Indication: Lung Disorder
Start date: 2011-01-24
End date: 2011-02-01
Ritonavir
Administration route: Oral
Indication: HIV Infection
End date: 2012-02-01
Other drugs received by patient: Reyataz; Minirinmelt; Diazepam; Truvada; Trimeprazine Tartrate
Possible Risperdal side effects in 71 year old male
Reported by a physician from Spain on 2012-05-22
Patient: 71 year old male
Reactions: Hypotension, Tachycardia, Drug Interaction, Epistaxis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Risperdal
Other drugs received by patient possibly interacting with the suspect drug:
Azilect
Administration route: Oral
Indication: Parkinson's Disease
Start date: 2007-01-01
End date: 2011-08-20
Escitalopram
Administration route: Oral
Indication: Parkinson's Disease
Start date: 2008-08-01
End date: 2011-08-20
Quetiapine
Administration route: Oral
Indication: Parkinson's Disease
Start date: 2010-08-01
End date: 2011-08-20
Other drugs received by patient: Simvastatin
Possible Risperdal side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-16
Patient: female
Reactions: Hepatic Enzyme Abnormal, Hepatic Steatosis
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Risperdal
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Zyprexa
Administration route: Oral
Indication: Product Used FOR Unknown Indication
End date: 2012-03-29
Other drugs received by patient: Citalopram Hydrobromide; Imovane
Page 1 Next >>
|
